Quarterly Vanguard Forum for Life Sciences Leaders - Online, February 18, 2021
Making Population Health a Competitive Edge
Accelerating Development: What Should We Learn From the COVID-19 Vaccines and Therapeutics?
February 18, 2021, Noon to 2 p.m. EST
This Forum was presented at the request of several of our Life Sciences Leaders members. We worked on two critical challenges for 2021: What do we need to know about Population Health to enable better therapies, faster AND what should we learn from the COVID 19 vaccines about accelerating development of other products?
Each session was led by fellow Life Sciences Leaders with deep experience in the topics. Cameron Durrant, Chairman/CEO Humanigen, Inc. was be the Forum Chair.
Throughout 2021, our quarterly Vanguard mini-forums for Life Sciences Leaders will address leadership challenges like these through intimate, interactive dialogues in a variety of engaging formats.
Forums are complimentary for Vanguard Network members. If you are not a member, you can apply here, or you’ll be asked to contribute a guest fee of $100 when we send you your invitation link.
SESSION LEADERS and ADVISORY BOARD
Session leaders for the mini-forums are highly experienced Life Sciences Leaders, board members, and top leadership experts.
Advisory board members help us plan the forum agendas, which focus on the topics most important to Life Sciences Leaders. Board members include:
Carrie Cox, Chairman of the Board, NewCo
Cameron Durrant, Chairman and CEO, Humanigen
Amber Edwards, Chief Commercial Officer, Alastin Inc.
Vivek Ramaswamy, Founder and CEO, Roivant Sciences
Davidi Vortman, CEO, OnSight Medical